(Q81805914)
Statements
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2 (English)
Satoshi Wada
Takuya Tsunoda
Toshiyuki Baba
F James Primus
Hiroyuki Kuwano
Masabumi Shibuya